Publications 2020

Valestrand L, Berntsen NL, Zheng F, Schrumpf E, Hansen SH, Karlsen TH, Blumberg RS, Hov JR, Jiang X, Melum E (2020)
Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells
Clin Exp Immunol, 203 (2), 304-314
DOI 10.1111/cei.13541, PubMed 33089489

Publications 2018

Berntsen NL, Fosby B, Tan C, Reims HM, Ogaard J, Jiang X, Schrumpf E, Valestrand L, Karlsen TH, Line PD, Blumberg RS, Melum E (2018)
Natural killer T cells mediate inflammation in the bile ducts
Mucosal Immunol, 11 (6), 1582-1590
DOI 10.1038/s41385-018-0066-8, PubMed 30115993

Publications 2017

Alberts R, de Vries EMG, Goode EC, Jiang X, Sampaziotis F, Rombouts K, Böttcher K, Folseraas T, Weismüller TJ, Mason AL, Wang W, Alexander G, Alvaro D, Bergquist A, Björkström NK, Beuers U, Björnsson E, Boberg KM, Bowlus CL, Bragazzi MC, Carbone M, Chazouillères O, Cheung A, Dalekos G, Eaton J et al. (2017)
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis
Gut, 67 (8), 1517-1524
DOI 10.1136/gutjnl-2016-313598, PubMed 28779025

Fickert P, Hirschfield GM, Denk G, Marschall HU, Altorjay I, Färkkilä M, Schramm C, Spengler U, Chapman R, Bergquist A, Schrumpf E, Nevens F, Trivedi P, Reiter FP, Tornai I, Halilbasic E, Greinwald R, Pröls M, Manns MP, Trauner M, European PSC norUDCA Study Group (2017)
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
J Hepatol, 67 (3), 549-558
DOI 10.1016/j.jhep.2017.05.009, PubMed 28529147

Vesterhus M, Holm A, Hov JR, Nygård S, Schrumpf E, Melum E, Thorbjørnsen LW, Paulsen V, Lundin K, Dale I, Gilja OH, Zweers SJLB, Vatn M, Schaap FG, Jansen PLM, Ueland T, Røsjø H, Moum B, Ponsioen CY, Boberg KM, Färkkilä M, Karlsen TH, Lund-Johansen F (2017)
Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis
J Hepatol, 66 (6), 1214-1222
DOI 10.1016/j.jhep.2017.01.019, PubMed 28161472

Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E et al. (2017)
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
Gastroenterology, 152 (8), 1975-1984.e8
DOI 10.1053/j.gastro.2017.02.038, PubMed 28274849

Publications 2016

Hov JR, Boberg KM, Taraldsrud E, Vesterhus M, Boyadzhieva M, Solberg IC, Schrumpf E, Vatn MH, Lie BA, Molberg Ø, Karlsen TH (2016)
Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis
Liver Int, 37 (3), 458-465
DOI 10.1111/liv.13238, PubMed 27558072

Kummen M, Holm K, Anmarkrud JA, Nygård S, Vesterhus M, Høivik ML, Trøseid M, Marschall HU, Schrumpf E, Moum B, Røsjø H, Aukrust P, Karlsen TH, Hov JR (2016)
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
Gut, 66 (4), 611-619
DOI 10.1136/gutjnl-2015-310500, PubMed 26887816

Publications 2015

Andersen IM, Fosby B, Boberg KM, Clausen OP, Jebsen P, Melum E, Line PD, Foss A, Schrumpf E, Karlsen TH (2015)
Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway
Transplant Direct, 1 (9), e39
DOI 10.1097/TXD.0000000000000548, PubMed 27500239

Andresen K, Boberg KM, Vedeld HM, Honne H, Jebsen P, Hektoen M, Wadsworth CA, Clausen OP, Lundin KE, Paulsen V, Foss A, Mathisen Ø, Aabakken L, Schrumpf E, Lothe RA, Lind GE (2015)
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma
Hepatology, 61 (5), 1651-9
DOI 10.1002/hep.27707, PubMed 25644509

Fosby B, Melum E, Bjøro K, Bennet W, Rasmussen A, Andersen IM, Castedal M, Olausson M, Wibeck C, Gotlieb M, Gjertsen H, Toivonen L, Foss S, Makisalo H, Nordin A, Sanengen T, Bergquist A, Larsson ME, Soderdahl G, Nowak G, Boberg KM, Isoniemi H, Keiding S, Foss A, Line PD et al. (2015)
Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013
Scand J Gastroenterol, 50 (6), 797-808
DOI 10.3109/00365521.2015.1036359, PubMed 25959101

Ponsioen CY, Chapman RW, Chazouillères O, Hirschfield GM, Karlsen TH, Lohse AW, Pinzani M, Schrumpf E, Trauner M, Gores GJ (2015)
Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process
Hepatology, 63 (4), 1357-67
DOI 10.1002/hep.28256, PubMed 26418478

Schrumpf E, Boberg KM, Karlsen TH (2015)
Primary sclerosing cholangitis - the Norwegian experience
Scand J Gastroenterol, 50 (6), 781-96
DOI 10.3109/00365521.2015.1028996, PubMed 25866138

Vesterhus M, Hov JR, Holm A, Schrumpf E, Nygård S, Godang K, Andersen IM, Naess S, Thorburn D, Saffioti F, Vatn M, Gilja OH, Lund-Johansen F, Syversveen T, Brabrand K, Parés A, Ponsioen CY, Pinzani M, Färkkilä M, Moum B, Ueland T, Røsjø H, Rosenberg W, Boberg KM, Karlsen TH (2015)
Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
Hepatology, 62 (1), 188-97
DOI 10.1002/hep.27825, PubMed 25833813

Publications 2014

Naess S, Björnsson E, Anmarkrud JA, Al Mamari S, Juran BD, Lazaridis KN, Chapman R, Bergquist A, Melum E, Marsh SG, Schrumpf E, Lie BA, Boberg KM, Karlsen TH, Hov JR (2014)
Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease
Liver Int, 34 (10), 1488-95
DOI 10.1111/liv.12492, PubMed 24517468

Næss S, Lie BA, Melum E, Olsson M, Hov JR, Croucher PJ, Hampe J, Thorsby E, Bergquist A, Traherne JA, Schrumpf E, Boberg KM, Schreiber S, Franke A, Karlsen TH (2014)
Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population
PLoS One, 9 (12), e114486
DOI 10.1371/journal.pone.0114486, PubMed 25521205

Publications 2013

Ellinghaus D, Folseraas T, Holm K, Ellinghaus E, Melum E, Balschun T, Laerdahl JK, Shiryaev A, Gotthardt DN, Weismüller TJ, Schramm C, Wittig M, Bergquist A, Björnsson E, Marschall HU, Vatn M, Teufel A, Rust C, Gieger C, Wichmann HE, Runz H, Sterneck M, Rupp C, Braun F, Weersma RK et al. (2013)
Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4
Hepatology, 58 (3), 1074-83
DOI 10.1002/hep.25977, PubMed 22821403

Jørgensen KK, Lindström L, Cvancarova M, Karlsen TH, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM (2013)
Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease
Clin Gastroenterol Hepatol, 11 (5), 517-23
DOI 10.1016/j.cgh.2012.12.027, PubMed 23333218

Kummen M, Schrumpf E, Boberg KM (2013)
Liver abnormalities in bowel diseases
Best Pract Res Clin Gastroenterol, 27 (4), 531-42
DOI 10.1016/j.bpg.2013.06.013, PubMed 24090940

Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Müller T, Srivastava B, Dalekos G, Nöthen MM, Herms S et al. (2013)
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
Nat Genet, 45 (6), 670-5
DOI 10.1038/ng.2616, PubMed 23603763

Publications 2012

Andresen K, Boberg KM, Vedeld HM, Honne H, Hektoen M, Wadsworth CA, Clausen OP, Karlsen TH, Foss A, Mathisen O, Schrumpf E, Lothe RA, Lind GE (2012)
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
Epigenetics, 7 (11), 1249-57
DOI 10.4161/epi.22191, PubMed 22983262

Folseraas T, Melum E, Rausch P, Juran BD, Ellinghaus E, Shiryaev A, Laerdahl JK, Ellinghaus D, Schramm C, Weismüller TJ, Gotthardt DN, Hov JR, Clausen OP, Weersma RK, Janse M, Boberg KM, Björnsson E, Marschall HU, Cleynen I, Rosenstiel P, Holm K, Teufel A, Rust C, Gieger C, Wichmann HE et al. (2012)
Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci
J Hepatol, 57 (2), 366-75
DOI 10.1016/j.jhep.2012.03.031, PubMed 22521342

Jørgensen KK, Lindström L, Cvancarova M, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM (2012)
Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study
Scand J Gastroenterol, 47 (8-9), 1021-9
DOI 10.3109/00365521.2012.685754, PubMed 22577871

Publications 2011

Hov JR, Keitel V, Schrumpf E, Häussinger D, Karlsen TH (2011)
TGR5 sequence variation in primary sclerosing cholangitis
Dig Dis, 29 (1), 78-84
DOI 10.1159/000324138, PubMed 21691110

Hov JR, Kosmoliaptsis V, Traherne JA, Olsson M, Boberg KM, Bergquist A, Schrumpf E, Bradley JA, Taylor CJ, Lie BA, Trowsdale J, Karlsen TH (2011)
Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis
Hepatology, 53 (6), 1967-76
DOI 10.1002/hep.24299, PubMed 21413052

Janse M, Lamberts LE, Franke L, Raychaudhuri S, Ellinghaus E, Muri Boberg K, Melum E, Folseraas T, Schrumpf E, Bergquist A, Björnsson E, Fu J, Jan Westra H, Groen HJ, Fehrmann RS, Smolonska J, van den Berg LH, Ophoff RA, Porte RJ, Weismüller TJ, Wedemeyer J, Schramm C, Sterneck M, Günther R, Braun F et al. (2011)
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9
Hepatology, 53 (6), 1977-85
DOI 10.1002/hep.24307, PubMed 21425313

Jørgensen KK, Grzyb K, Lundin KE, Clausen OP, Aamodt G, Schrumpf E, Vatn MH, Boberg KM (2011)
Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients
Inflamm Bowel Dis, 18 (3), 536-45
DOI 10.1002/ibd.21699, PubMed 21456044

Publications 2010

Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E, International Autoimmune Hepatitis Group (2010)
Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue
J Hepatol, 54 (2), 374-85
DOI 10.1016/j.jhep.2010.09.002, PubMed 21067838

Hov JR, Keitel V, Laerdahl JK, Spomer L, Ellinghaus E, ElSharawy A, Melum E, Boberg KM, Manke T, Balschun T, Schramm C, Bergquist A, Weismüller T, Gotthardt D, Rust C, Henckaerts L, Onnie CM, Weersma RK, Sterneck M, Teufel A, Runz H, Stiehl A, Ponsioen CY, Wijmenga C, Vatn MH et al. (2010)
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis
PLoS One, 5 (8), e12403
DOI 10.1371/journal.pone.0012403, PubMed 20811628

Karlsen TH, Schrumpf E, Boberg KM (2010)
Update on primary sclerosing cholangitis
Dig Liver Dis, 42 (6), 390-400
DOI 10.1016/j.dld.2010.01.011, PubMed 20172772

Karlsen TH, Schrumpf E, Boberg KM (2010)
Primary sclerosing cholangitis
Best Pract Res Clin Gastroenterol, 24 (5), 655-66
DOI 10.1016/j.bpg.2010.07.005, PubMed 20955968

Melum E, Franke A, Schramm C, Weismüller TJ, Gotthardt DN, Offner FA, Juran BD, Laerdahl JK, Labi V, Björnsson E, Weersma RK, Henckaerts L, Teufel A, Rust C, Ellinghaus E, Balschun T, Boberg KM, Ellinghaus D, Bergquist A, Sauer P, Ryu E, Hov JR, Wedemeyer J, Lindkvist B, Wittig M et al. (2010)
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci
Nat Genet, 43 (1), 17-9
DOI 10.1038/ng.728, PubMed 21151127

Ponsioen CY, Reitsma JB, Boberg KM, Aabakken L, Rauws EA, Schrumpf E (2010)
Validation of a cholangiographic prognostic model in primary sclerosing cholangitis
Endoscopy, 42 (9), 742-7
DOI 10.1055/s-0030-1255527, PubMed 20623444

Publications 2009

Forsbring M, Vik ES, Dalhus B, Karlsen TH, Bergquist A, Schrumpf E, Bjørås M, Boberg KM, Alseth I (2009)
Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma
Carcinogenesis, 30 (7), 1147-54
DOI 10.1093/carcin/bgp118, PubMed 19443904

Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, Lie BA, Bergquist A, Schramm C, Weismüller TJ, Gotthardt D, Rust C, Philipp EE, Fritz T, Henckaerts L, Weersma RK, Stokkers P, Ponsioen CY, Wijmenga C, Sterneck M, Nothnagel M, Hampe J, Teufel A, Runz H, Rosenstiel P et al. (2009)
Genome-wide association analysis in primary sclerosing cholangitis
Gastroenterology, 138 (3), 1102-11
DOI 10.1053/j.gastro.2009.11.046, PubMed 19944697

Scholz T, Karlsen TH, Sanengen T, Schrumpf E, Line PD, Boberg KM, Jörgensen PF, Fosby B, Bentdal O, Ostensen AB, Osnes S, Riddervold F, Haugaa H, Hausken J, Bergmann JB, Foss S, Björo K, Foss A, Levertransplantasjonsgruppen ved Oslo universitetssykehus, Rikshospitalet (2009)
[Liver transplantation in Norway through 25 years]
Tidsskr Nor Laegeforen, 129 (24), 2587-92
DOI 10.4045/tidsskr.09.1106, PubMed 20029553

Publications 2008

Karlsen TH, Schrumpf E, Boberg KM (2008)
Gallbladder polyps in primary sclerosing cholangitis: not so benign
Curr Opin Gastroenterol, 24 (3), 395-9
DOI 10.1097/MOG.0b013e3282f5727a, PubMed 18408471

Melum E, Karlsen TH, Bergquist A, Schrumpf E, Boberg KM (2008)
An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis
Am J Gastroenterol, 103 (4), 1045; author reply 1045-6
DOI 10.1111/j.1572-0241.2007.01772_5.x, PubMed 18397431

Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, Lie BA (2008)
Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms
Hepatology, 47 (1), 90-6
DOI 10.1002/hep.21964, PubMed 18023027

Publications 2007

Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, Schrumpf E, Thorsby E, Lie BA (2007)
Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis
J Hepatol, 46 (5), 899-906
DOI 10.1016/j.jhep.2007.01.032, PubMed 17383044

Karlsen TH, Boberg KM, Vatn M, Bergquist A, Hampe J, Schrumpf E, Thorsby E, Schreiber S, Lie BA, IBSEN Study Group (2007)
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis
Genes Immun, 8 (3), 275-8
DOI 10.1038/sj.gene.6364377, PubMed 17301827

Karlsen TH, Schrumpf E, Boberg KM (2007)
Genetic epidemiology of primary sclerosing cholangitis
World J Gastroenterol, 13 (41), 5421-31
DOI 10.3748/wjg.v13.i41.5421, PubMed 17907284

Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA, Spurkland A (2007)
Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes
Tissue Antigens, 69 (2), 161-9
DOI 10.1111/j.1399-0039.2006.00738.x, PubMed 17257319

Publications 2006

Berstad AE, Aabakken L, Smith HJ, Aasen S, Boberg KM, Schrumpf E (2006)
Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis
Clin Gastroenterol Hepatol, 4 (4), 514-20
DOI 10.1016/j.cgh.2005.10.007, PubMed 16616358

Bjøro K, Brandsaeter B, Foss A, Schrumpf E (2006)
Liver transplantation in primary sclerosing cholangitis
Semin Liver Dis, 26 (1), 69-79
DOI 10.1055/s-2006-933565, PubMed 16496235

Boberg KM, Foss A, Midtvedt K, Schrumpf E (2006)
ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody
Clin Transplant, 20 (2), 265-8
DOI 10.1111/j.1399-0012.2005.00470.x, PubMed 16640538

Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E (2006)
Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis
J Hepatol, 45 (4), 568-74
DOI 10.1016/j.jhep.2006.05.010, PubMed 16879890

Bowlus CL, Karlsen TH, Broomé U, Thorsby E, Vatn M, Schrumpf E, Lie BA, Boberg KM (2006)
Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis
J Hepatol, 45 (5), 704-10
DOI 10.1016/j.jhep.2006.03.012, PubMed 16750586

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM (2006)
Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis
Am J Gastroenterol, 102 (1), 115-21
DOI 10.1111/j.1572-0241.2006.00928.x, PubMed 17100974

Karlsen TH, Lie BA, Frey Frøslie K, Thorsby E, Broomé U, Schrumpf E, Boberg KM (2006)
Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis
Gastroenterology, 131 (3), 781-7
DOI 10.1053/j.gastro.2006.05.057, PubMed 16952547

Melum E, Karlsen TH, Broomé U, Thorsby E, Schrumpf E, Boberg KM, Lie BA (2006)
The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients
Tissue Antigens, 68 (1), 78-81
DOI 10.1111/j.1399-0039.2006.00604.x, PubMed 16774544

Melum E, Schrumpf E, Bjøro K (2006)
Liver TX for hepatitis C cirrhosis in a low prevalence population: risk factors and status at evaluation
Scand J Gastroenterol, 41 (5), 592-6
DOI 10.1080/00365520500347113, PubMed 16638703

Slinning C, Bjøro K, Boberg KM, Schrumpf E (2006)
[Fulminant hepatic failure in malignant liver disease]
Tidsskr Nor Laegeforen, 126 (7), 917-8
PubMed 16554884

Wiencke K, Boberg KM, Donaldson P, Harbo H, Ling V, Schrumpf E, Spurkland A (2006)
No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis
Scand J Gastroenterol, 41 (5), 586-91
DOI 10.1080/00365520500377870, PubMed 16638702

Publications 2005

Boberg KM, Schrumpf E (2005)
Prognosis of autoimmune liver diseases
FALK SYMP, 142, 233-246

Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Friman S, Bjoro K, Schrumpf E, Nordic Liver Transplantation Grp (2005)
Chernopreventive effect of ursodeoxycholic acid in primary sclerosing cholangitis?
FALK SYMP, 141, 242-249

Brandsaeter B, Schrumpf E, Bentdal O, Brabrand K, Smith HJ, Abildgaard A, Clausen OP, Bjoro K (2005)
Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors
Liver Transpl, 11 (11), 1361-9
DOI 10.1002/lt.20444, PubMed 16184522

Schrumpf E, Boberg KM (2005)
Standard treatment for primary sclerosing cholangitis and overlap autoimmune hepatitis/primary sclerosing cholangitis
FALK SYMP, 142, 203-207

Publications 2004

Bjøro K, Schrumpf E (2004)
Liver transplantation for primary sclerosing cholangitis
J Hepatol, 40 (4), 570-7
DOI 10.1016/j.jhep.2004.01.021, PubMed 15030971

Boberg KM, Clausen ORF, Schrumpf E (2004)
Primary sclerosing cholangitis: diagnosis and differential diagnosis
FALK SYMP, 136, 203-217

Boberg KM, Schrumpf E (2004)
Diagnosis and treatment of cholangiocarcinoma
Curr Gastroenterol Rep, 6 (1), 52-9
DOI 10.1007/s11894-004-0026-1, PubMed 14720454

Brandsaeter B, Isoniemi H, Broomé U, Olausson M, Bäckman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Höckerstedt K, Mäkisalo H, Kirkegaard P, Friman S, Bjøro K (2004)
Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy
J Hepatol, 40 (5), 815-22
DOI 10.1016/j.jhep.2004.01.002, PubMed 15094230

Brandsaeter B, Schrumpf E, Clausen OP, Abildgaard A, Hafsahl G, Bjøro K (2004)
Recurrent sclerosing cholangitis or ischemic bile duct lesions--a diagnostic challenge?
Liver Transpl, 10 (8), 1073-4
DOI 10.1002/lt.20192, PubMed 15390337

Schrumpf E, Boberg KM (2004)
Primary sclerosing cholangitis and inflammatory bowel disease: when and how do they relate to each other?
FALK SYMP, 136, 283-288

Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM, IBSEN Study Group (2004)
Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients
J Hepatol, 41 (2), 209-14
DOI 10.1016/j.jhep.2004.04.024, PubMed 15288468

Publications 2003

Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
Scand J Gastroenterol, 38 (3), 320-7
DOI 10.1080/00365520310000681, PubMed 12737449

Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary Osteoporosis in Liver Transplant Recipients: a Longitudinal Study in Patients With and Without Cholestatic Liver Disease
Scand J Gastroenterol, 38 (3), 320-327
DOI 10.1080/00365520310000681, PubMed 28248598

Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 38(2003)3, s.320-7
BIBSYS 041707508

Boberg KM, Egeland T, Schrumpf E (2003)
Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients
Scand J Gastroenterol, 38 (9), 991-5
DOI 10.1080/00365520310005172, PubMed 14531538

Boberg KM, Jebsen P, Clausen OP, Aabakken L, Brekke I, Schrumpf E (2003)
Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation
J Hepatol, 39 (3), 453
DOI 10.1016/s0168-8278(03)00326-x, PubMed 12927935

Brandsaeter B, Broomé U, Isoniemi H, Friman S, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Höckerstedt K, Mäkisalo H, Olsson R, Olausson M, Kirkegaard P, Bjøro K (2003)
Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list
Liver Transpl, 9 (9), 961-9
DOI 10.1053/jlts.2003.50169, PubMed 12942458

Brandsaeter B, Friman S, Broomé U, Isoniemi H, Olausson M, Bäckman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Höckerstedt K, Mäkisalo H, Kirkegaard P, Bjøro K (2003)
Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries
Scand J Gastroenterol, 38 (11), 1176-83
DOI 10.1080/00365520310006009, PubMed 14686722

Schrumpf E, Boberg KM (2003)
Hepatic and extrahepatic malignancies and primary sclerosing cholangitis
Gut, 52 (2), 165
DOI 10.1136/gut.52.2.165, PubMed 12524391

Publications 2002

Björnsson E, Boberg KM, Cullen S, Fleming K, Clausen OP, Fausa O, Schrumpf E, Chapman RW (2002)
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis
Gut, 51 (5), 731-5
DOI 10.1136/gut.51.5.731, PubMed 12377815

Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broomé U, Chapman R, Fausa O, Egeland T, Rocca G, Schrumpf E (2002)
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation
Scand J Gastroenterol, 37 (10), 1205-11
DOI 10.1080/003655202760373434, PubMed 12408527

Boberg KM, Rocca G, Egeland T, Bergquist A, Broomé U, Caballeria L, Chapman R, Hultcrantz R, Mitchell S, Pares A, Rosina F, Schrumpf E (2002)
Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis
Hepatology, 35 (3), 652-7
DOI 10.1053/jhep.2002.31872, PubMed 11870380

Schrumpf E, Boberg KM (2002)
Endoscopic treatment for primary sclerosing cholangitis?
J Hepatol, 36 (2), 278-9
DOI 10.1016/s0168-8278(01)00292-6, PubMed 11830341

Publications 2001

Bjøro K, Kirkegaard P, Ericzon BG, Friman S, Schrumpf E, Isoniemi H, Herlenius G, Olausson M, Rasmussen A, Foss A, Höckerstedt K (2001)
Is a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect?
Transplant Proc, 33 (4), 2511-3
DOI 10.1016/s0041-1345(01)02080-2, PubMed 11406230

Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S, Broomé U, Chapman R, Olerup O, Pares A, Rosina F, Schrumpf E (2001)
The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis
Scand J Gastroenterol, 36 (8), 886-90
DOI 10.1080/003655201750313441, PubMed 11495087

Leidenius M, Höckersted K, Broomé U, Ericzon BG, Friman S, Olausson M, Schrumpf E (2001)
Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study
J Hepatol, 34 (6), 792-8
DOI 10.1016/s0168-8278(01)00042-3, PubMed 11451160

Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP, Schrumpf E, Chapman RW, European Study Group of Primary Sclerosing Cholangitis (2001)
Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis
Gut, 49 (2), 288-94
DOI 10.1136/gut.49.2.288, PubMed 11454808

Offstad J, Schrumpf E, Geiran O, Søreide O, Simonsen S (2001)
Plasma exchange and heart-liver transplantation in a patient with homozygous familial hypercholesterolemia
Clin Transplant, 15 (6), 432-6
DOI 10.1034/j.1399-0012.2001.150612.x, PubMed 11737122

Schrumpf E, Boberg KM (2001)
Epidemiology of primary sclerosing cholangitis
Best Pract Res Clin Gastroenterol, 15 (4), 553-62
DOI 10.1053/bega.2001.0204, PubMed 11492967

Wiencke K, Spurkland A, Schrumpf E, Boberg KM (2001)
Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles
Hepatology, 34 (4 Pt 1), 625-30
DOI 10.1053/jhep.2001.27543, PubMed 11584356

Publications 2000

Bjøro K, Höckerstedt K, Ericzon BG, Friman S, Hjortrup A, Keiding S, Schrumpf E, Duraj F, Olausson M, Mäkisalo H, Bergan A, Kirkegaard P (2000)
Liver transplantation in patients over 60 years of age
Transpl Int, 13 Suppl 1, S165-70
DOI 10.1007/s001470050315, PubMed 11111989

Boberg KM, Schrumpf E, Bergquist A, Broomé U, Pares A, Remotti H, Schjölberg A, Spurkland A, Clausen OP (2000)
Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development
J Hepatol, 32 (3), 374-80
DOI 10.1016/s0168-8278(00)80386-4, PubMed 10735605

Schrumpf E, Boberg KM (2000)
Primary sclerosing cholangitis: challenges of a new millenium
Dig Liver Dis, 32 (9), 753-5
DOI 10.1016/s1590-8658(00)80350-3, PubMed 11215553

Publications 1999

Bjøro K, Friman S, Höckerstedt K, Kirkegaard P, Keiding S, Schrumpf E, Olausson M, Oksanen A, Isoniemi H, Hjortrup A, Bergan A, Ericzon BG (1999)
Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results
Scand J Gastroenterol, 34 (7), 714-22
DOI 10.1080/003655299750025930, PubMed 10466884

Boberg KM, Brosstad F, Egeland T, Egge T, Schrumpf E (1999)
Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy?
Thromb Haemost, 81 (3), 378-81
PubMed 10102464

Giercksky T, Boberg KM, Farstad IN, Halvorsen S, Schrumpf E (1999)
Severe liver failure in exertional heat stroke
Scand J Gastroenterol, 34 (8), 824-7
DOI 10.1080/003655299750025778, PubMed 10499485

Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, Knutsen I, Pares A, Rosina F, Olerup O, Thorsby E, Schrumpf E (1999)
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations
Tissue Antigens, 53 (5), 459-69
DOI 10.1034/j.1399-0039.1999.530502.x, PubMed 10372541

Søreide O, Husberg B, Bjøro K, Schrumpf E (1999)
[Liver transplantation--development and experiences]
Tidsskr Nor Laegeforen, 119 (22), 3310-4
PubMed 10533415

Publications 1998

Bjøro K, Gjerstad L, Bentdal O, Osnes S, Schrumpf E (1998)
Topiramate and fulminant liver failure
Lancet, 352 (9134), 1119
DOI 10.1016/s0140-6736(05)79759-2, PubMed 9798593

Bjøro K, Schrumpf E, Bergan A, Haaland T, Skaug K, Frøland SS (1998)
Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia
Scand J Infect Dis, 30 (5), 520-2
DOI 10.1080/00365549850161575, PubMed 10066058

Aabakken L, Schrumpf E, Søreide O (1998)
The Internet--friend or foe to scientific journals?
Scand J Gastroenterol, 33 (3), 223
DOI 10.1080/00365529850170757, PubMed 9548611

Publications 1997

Bansi DS, Bauducci M, Bergqvist A, Boberg K, Broome U, Chapman R, Fleming K, Jorgensen R, Lindor K, Rosina F, Schrumpf E (1997)
Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques
Eur J Gastroenterol Hepatol, 9 (6), 575-80
DOI 10.1097/00042737-199706000-00005, PubMed 9222729

Bjøro K, Blomhoff JP, Schrumpf E, Brosstad F, Bergan A, Egge T (1997)
[Hepatic vein thrombosis. Diagnostic and therapeutic difficulties]
Tidsskr Nor Laegeforen, 117 (9), 1274-6
PubMed 9182354

Boberg KM, Schrumpf E (1997)
[Treatment of cholestatic liver diseases with ursodeoxycholic acid]
Tidsskr Nor Laegeforen, 117 (23), 3370-3
PubMed 9411890

Nordøy I, Krarup HB, Bell H, Christensen PB, Elgjo K, von der Lippe B, De Muckadell OS, Maeland A, Ring-Larsen H, Samdal HH, Simmonds P, Skaug K, Tage-Jensen U, Schrumpf E (1997)
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study
Scand J Gastroenterol, 32 (12), 1256-60
DOI 10.3109/00365529709028156, PubMed 9438325

Schrumpf E, Søreide O, Aabakken L (1997)
How to report randomized controlled trials. The CONSORT statement. Consolidated Standards Of Reporting Trials
Scand J Gastroenterol, 32 (12), 1185-6
DOI 10.3109/00365529709028143, PubMed 9438312

Publications 1996

Bjøro K, Schrumpf E, Bergan A, Flatmark A, Mathisen O, Sødal G, Søreide O, Sanengen T, Innes R, Osnes S (1996)
[Liver transplantation in Norway. Results after 10 years and 114 transplantations]
Tidsskr Nor Laegeforen, 116 (1), 19-24
PubMed 8553329

Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, Schrumpf E (1996)
Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis
Hepatology, 23 (6), 1369-76
DOI 10.1002/hep.510230612, PubMed 8675153

Norheim OF, Bjøoro K, Schrumpf E, Søreide O (1996)
[Is liver transplantation a therapeutic possibility of low priority in Norway?]
Tidsskr Nor Laegeforen, 116 (1), 72-6
PubMed 8553343

Schrumpf E, Bjøro K, Bell H, Harthug S, Hellum KB, Myrvang B, Maeland A, Ritland S (1996)
[Treatment of hepatitis C]
Tidsskr Nor Laegeforen, 116 (15), 1792-4
PubMed 8693463

Publications 1995

Bjøro K, Schrumpf E, Elgjo K, Kolmanskog F (1995)
Monstrous ascites in hereditary haemorrhagic telangiectasia
Scand J Gastroenterol, 30 (1), 92-4
DOI 10.3109/00365529509093242, PubMed 7701258

Jacobsen MB, Hanssen LE, Kolmannskog F, Schrumpf E, Vatn MH, Bergan A (1995)
Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study
Scand J Gastroenterol, 30 (8), 789-96
DOI 10.3109/00365529509096329, PubMed 7481548

Opper C, Schrumpf E, Gear AR, Wesemann W (1995)
Involvement of guanylate cyclase and phosphodiesterases in the functional heterogeneity of human blood platelet subpopulations
Thromb Res, 80 (6), 461-70
DOI 10.1016/0049-3848(95)00201-4, PubMed 8610274

Aaseth J, Thomassen Y, Aadland E, Fausa O, Schrumpf E (1995)
Hepatic retention of copper and selenium in primary sclerosing cholangitis
Scand J Gastroenterol, 30 (12), 1200-3
DOI 10.3109/00365529509101631, PubMed 9053974

Publications 1994

Boberg KM, Lundin KE, Schrumpf E (1994)
Etiology and pathogenesis in primary sclerosing cholangitis
Scand J Gastroenterol Suppl, 204, 47-58
DOI 10.3109/00365529409103625, PubMed 7824878

Boberg KM, Schrumpf E, Fausa O, Elgjo K, Kolmannskog F, Haaland T, Holter E (1994)
Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis
Scand J Gastroenterol, 29 (8), 744-52
DOI 10.3109/00365529409092504, PubMed 7973436

Boberg KM, Schrumpf E, Rogstad B, Berg KJ, Ganes T, Bergan A (1994)
[Treatment of paracetamol poisoning. An indication for liver transplantation?]
Tidsskr Nor Laegeforen, 114 (10), 1199-203
PubMed 8209319

Höckerstedt K, Isoniemi H, Ericzon BG, Broomé U, Friman S, Persson H, Bergan A, Schrumpf E, Kirkegaard P, Hjortrup A (1994)
Is a 3-day waiting list appropriate for patients with acute liver failure?
Transplant Proc, 26 (3), 1786-7
PubMed 8030134

Kolmannskog F, Jakobsen JA, Schrumpf E, Bergan A (1994)
Duplex Doppler sonography and angiography in the evaluation for liver transplantation
Acta Radiol, 35 (1), 1-5
PubMed 8305264

Nordøy I, Schrumpf E, Elgjo K, Flesland O, Andersen Glende J, Orjasaeter H, Siebke JC (1994)
Liver disease in anti-hepatitis C virus-positive Norwegian blood donors
Scand J Gastroenterol, 29 (1), 77-81
DOI 10.3109/00365529409090441, PubMed 8128181

Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F (1994)
Risk factors in primary sclerosing cholangitis
J Hepatol, 21 (6), 1061-6
DOI 10.1016/s0168-8278(05)80618-x, PubMed 7699228

Vetvik K, Schrumpf E, Mowinckel P, Aase S, Andersen KJ (1994)
Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients
Scand J Gastroenterol, 29 (11), 995-1000
DOI 10.3109/00365529409094876, PubMed 7871380

Publications 1993

SCHRUMPF E (1993)
THE VIEW CONCERNING INDUSTRIAL CHILD LABOR - AN END TO THE MISERY READING
Hist. Tidsskr., 72 (2), 209-222

Publications 1992

Bjøro K, Schrumpf E (1992)
[Hepatitis C]
Tidsskr Nor Laegeforen, 112 (29), 3654-5
PubMed 1471122

Jacobsen MB, Bjøorneklett A, Schrumpf E (1992)
[Spontaneous bacterial peritonitis]
Tidsskr Nor Laegeforen, 112 (2), 199-201
PubMed 1566247

Moum B, Aukrust P, Schrumpf E, Mørk T, Mathisen O, Elgjo K (1992)
[Natural products can be hazardous to health]
Tidsskr Nor Laegeforen, 112 (10), 1308-11
PubMed 1579916

Søreide O, Berstad T, Bakka A, Schrumpf E, Hanssen LE, Engh V, Bergan A, Flatmark A (1992)
Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors
Surgery, 111 (1), 48-54
PubMed 1728075

Zauli D, Baffoni L, Cassani F, Fusconi M, Lenzi M, Ballardini G, Luigi M, Bianchi FB, Schrumpf E (1992)
Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases
Gastroenterology, 102 (3), 1088-90
DOI 10.1016/0016-5085(92)90213-i, PubMed 1537507

Publications 1991

Aspestrand F, Schrumpf E, Jacobsen M, Hanssen L, Endresen K (1991)
Increased lymphatic flow from the liver in different intra- and extrahepatic diseases demonstrated by CT
J Comput Assist Tomogr, 15 (4), 550-4
DOI 10.1097/00004728-199107000-00004, PubMed 2061465

BENDSTEN F, CHRISTENSEN E, HARDT F, HENRIKSEN JH, JUHL E, MATZEN P, RINGLARSEN H, SORENSEN TIA, ELSBORG L, ERIKSEN J, HAMBERG O, LINDAHL F, SANCHEZ G, DEMUCKADELL OS, SCHLICHTING P, SCHRUMPF E, SKOVBJERG H, WALMER I, ANDERSON PK, BILLEBRAHE NE, BONDESEN S, BURCHARTH F, FALLINGBORG J, FAUSA O, FREUND L et al. (1991)
PROPHYLAXIS OF 1ST HEMORRHAGE FROM ESOPHAGEAL-VARICES BY SCLEROTHERAPY, PROPRANOLOL OR BOTH IN CIRRHOTIC-PATIENTS - A RANDOMIZED MULTICENTER TRIAL
Hepatology, 14 (6), 1016-1024

Fausa O, Schrumpf E, Elgjo K (1991)
Relationship of inflammatory bowel disease and primary sclerosing cholangitis
Semin Liver Dis, 11 (1), 31-9
DOI 10.1055/s-2008-1040420, PubMed 2047887

Funk J, Langeland T, Schrumpf E, Hanssen LE (1991)
Psoriasis induced by interferon-alpha
Br J Dermatol, 125 (5), 463-5
DOI 10.1111/j.1365-2133.1991.tb14774.x, PubMed 1751354

Hagve TA, Myrseth LE, Schrumpf E, Blomhoff JP, Christophersen B, Elgjo K, Gjone E, Prydz H (1991)
Liver steatosis in hypobetalipoproteinemia. A case report
J Hepatol, 13 (1), 104-11
DOI 10.1016/0168-8278(91)90871-8, PubMed 1918873

Hanssen LE, Schrumpf E, Jacobsen MB, Kolbenstvedt AN, Kolmannskog F, Bergan A, Dolva LO (1991)
Extended experience with recombinant alpha-2b interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report
Acta Oncol, 30 (4), 523-7
DOI 10.3109/02841869109092412, PubMed 1854510

Kolmannskog F, Kolbenstvedt AN, Schrumpf E, Hanssen LE (1991)
Side effects and complications after hepatic artery embolization in the carcinoid syndrome
Scand J Gastroenterol, 26 (5), 557-62
DOI 10.3109/00365529108998580, PubMed 1871548

Vetvik K, Schrumpf E, Andersen KJ, Skagen DW, Halvorsen OJ (1991)
Effect of misoprostol and antacids on gastric and duodenal mucosal enzyme activities in duodenal ulcer patients
Scand J Gastroenterol, 26 (4), 385-91
DOI 10.3109/00365529108996499, PubMed 1903558

Publications 1990

Bell H, Schrumpf E, Fagerhol MK (1990)
Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease
Scand J Gastroenterol, 25 (8), 788-92
DOI 10.3109/00365529008999216, PubMed 2402584

Bjøro K, Schrumpf E, Elgjo K, Nordgård K (1990)
[Chronic non-A non-B hepatitis treated with interferon]
Tidsskr Nor Laegeforen, 110 (11), 1346-8
PubMed 2111053

Bjøro K, Vatn M, Schrumpf E, Ganes T, Lundar T, Bergan A (1990)
[Liver transplantation in fulminant hepatic failure]
Tidsskr Nor Laegeforen, 110 (26), 3372-5
PubMed 2256061

Haukenes G, Matre R, Tønder O, Myrmel H, Schrumpf E (1990)
Measles and rubella antibodies in patients with chronic liver disease
J Hepatol, 11 (3), 389
DOI 10.1016/0168-8278(90)90228-j, PubMed 2290032

Jacobsen MB, Fausa O, Elgjo K, Schrumpf E (1990)
Hepatic lesions in adult coeliac disease
Scand J Gastroenterol, 25 (7), 656-62
DOI 10.3109/00365529008997589, PubMed 2396080

Rydning A, Schrumpf E, Abdelnoor M, Elgjo K, Jenssen E (1990)
Factors of prognostic importance in primary biliary cirrhosis
Scand J Gastroenterol, 25 (2), 119-26
DOI 10.3109/00365529009107932, PubMed 2305209

Schrumpf E, Elgjo K, Fausa O, Haukenes G, Kvale D, Rollag H (1990)
The significance of anti-hepatitis C virus antibodies measured in chronic liver disease
Scand J Gastroenterol, 25 (11), 1169-74
DOI 10.3109/00365529008998550, PubMed 2177219

Schrumpf E, Fausa O, Aadland E, Elgjo K, Kolmannskog F (1990)
[Primary sclerosing cholangitis and inflammatory bowel disease]
Tidsskr Nor Laegeforen, 110 (10), 1212-6
PubMed 1970674

Vetvik K, Schrumpf E, Andersen KJ, Børkje B, Odegaard S, Skagen DW, Halvorsen OJ (1990)
Enzyme activities in the gastric mucosa in duodenal ulcer patients
Scand J Gastroenterol, 25 (6), 594-600
DOI 10.3109/00365529009095535, PubMed 2359990

Vetvik K, Schrumpf E, Andersen KJ, Skagen DW, Halvorsen OJ (1990)
Effect of ranitidine on gastric and duodenal mucosal enzyme activities in duodenal ulcer patients
Scand J Gastroenterol, 25 (11), 1123-8
DOI 10.3109/00365529008998544, PubMed 2274735

Publications 1989

Hanssen LE, Schrumpf E, Kolbenstvedt AN, Tausjø J, Dolva LO (1989)
Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization
Scand J Gastroenterol, 24 (7), 787-95
DOI 10.3109/00365528909089215, PubMed 2477894

Hanssen LE, Schrumpf E, Kolbenstvedt AN, Tausjø J, Dolva LO (1989)
Recombinant alpha-2 interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report
Acta Oncol, 28 (3), 439-43
DOI 10.3109/02841868909111219, PubMed 2742781

Haug K, Schrumpf E, Halvorsen JF, Fluge G, Hamre E, Hamre T, Skjøllingstad R (1989)
Epidemiology of Crohn's disease in western Norway. Study group of Inflammatory Bowel Disease in Western Norway
Scand J Gastroenterol, 24 (10), 1271-5
DOI 10.3109/00365528909090798, PubMed 2602908

Kalland KH, Endresen C, Haukenes G, Schrumpf E (1989)
Measles-specific nucleotide sequences and autoimmune chronic active hepatitis
Lancet, 1 (8651), 1390-1
DOI 10.1016/s0140-6736(89)92836-5, PubMed 2567403

Schrumpf E (1989)
Association of primary sclerosing cholangitis and celiac disease: fact or fancy?
Hepatology, 10 (6), 1020-1
DOI 10.1002/hep.1840100624, PubMed 2583678

Vetvik K, Schrumpf E, Andersen KJ, Børkje B, Skagen DW, Halvorsen OJ (1989)
Enzyme activities in the duodenal mucosa in duodenal ulcer patients
Scand J Gastroenterol, 24 (2), 244-50
DOI 10.3109/00365528909093042, PubMed 2928738

Publications 1988

Haug K, Schrumpf E, Barstad S, Fluge G, Halvorsen JF (1988)
Epidemiology of ulcerative colitis in western Norway
Scand J Gastroenterol, 23 (5), 517-22
DOI 10.3109/00365528809093904, PubMed 3399823

Høeg V, Schrumpf E, Blomhoff JP, Frøland S, Rollag H, Stokke O, Aasen AO (1988)
[Etiology of chronic pancreatitis]
Tidsskr Nor Laegeforen, 108 (31), 2834-7
PubMed 3201447

Schrumpf E, Fausa O, Elgjo K, Kolmannskog F (1988)
Hepatobiliary complications of inflammatory bowel disease
Semin Liver Dis, 8 (3), 201-9
DOI 10.1055/s-2008-1040541, PubMed 3068805

Publications 1987

Børkje B, Høstmark J, Skagen DW, Schrumpf E, Laerum OD (1987)
Flow cytometry of biopsy specimens from ulcerative colitis, colorectal adenomas, and carcinomas
Scand J Gastroenterol, 22 (10), 1231-7
DOI 10.3109/00365528708996469, PubMed 3433012

Børkje B, Laerum OD, Schrumpf E (1987)
Enzyme activities in biopsy specimens from large-bowel mucosa in ulcerative colitis
Scand J Gastroenterol, 22 (4), 443-8
DOI 10.3109/00365528708991488, PubMed 3602924

Børkje B, Laerum OD, Schrumpf E (1987)
Enzyme activities in biopsy specimens from large-bowel mucosa in colorectal adenomas and carcinomas
Scand J Gastroenterol, 22 (5), 533-8
DOI 10.3109/00365528708991893, PubMed 3629177

Haffner J, Linnestad P, Schrumpf E, Hanssen LE, Flaten O, Oyasaeter S (1987)
The immediate effect of human renal transplantation on basal and meal-stimulated levels of gastrointestinal hormones
Scand J Gastroenterol, 22 (1), 42-6
DOI 10.3109/00365528708991854, PubMed 2882597

Kvale D, Schrumpf E, Brandtzaeg P, Solberg HE, Fausa O, Elgjo K (1987)
Circulating secretory immunoglobulins of the A and M isotypes in chronic liver disease
J Hepatol, 4 (2), 229-35
DOI 10.1016/s0168-8278(87)80085-5, PubMed 3584932

Linnestad P, Hanssen LE, Schrumpf E, Slettebø M, Oyasaeter S (1987)
Diminution of postprandial release of pancreatic polypeptide in myotonic dystrophy
Acta Neurol Belg, 87 (2), 66-9
PubMed 3577661

Odegaard S, Høstmark J, Skagen DW, Schrumpf E, Laerum OD (1987)
Flow cytometric DNA studies in human gastric cancer and polyps
Scand J Gastroenterol, 22 (10), 1270-6
DOI 10.3109/00365528708996475, PubMed 3433017

Odegaard S, Høstmark J, Skagen DW, Schrumpf E, Laerum OD (1987)
Flow cytometric DNA studies in normal human gastric mucosa, gastritis, and resected stomachs
Scand J Gastroenterol, 22 (6), 750-6
DOI 10.3109/00365528709011154, PubMed 3659836

Saebø A, Schrumpf E, Maartman-Moe H (1987)
Chronic complaints and complement aberrations after acute Yersinia enterocolitica infection
Contrib Microbiol Immunol, 9, 155-60
PubMed 3665493

Schrumpf E, Fausa O, Aadland E (1987)
Primary sclerosing cholangitis
Scand J Gastroenterol, 22 (6), 641-3
DOI 10.3109/00365528709011136, PubMed 3659825

Zauli D, Schrumpf E, Crespi C, Cassani F, Fausa O, Aadland E (1987)
An autoantibody profile in primary sclerosing cholangitis
J Hepatol, 5 (1), 14-8
DOI 10.1016/s0168-8278(87)80055-7, PubMed 3498749

Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, Gjone E (1987)
Primary sclerosing cholangitis: a long-term follow-up study
Scand J Gastroenterol, 22 (6), 655-64
DOI 10.3109/00365528709011139, PubMed 3659828

Publications 1986

Børkje B, Odegaard S, Skagen DW, Andersen KJ, Schrumpf E (1986)
Enzyme activities in biopsy specimens from human gastric mucosa
Scand J Gastroenterol, 21 (9), 1051-7
DOI 10.3109/00365528608996419, PubMed 3810004

Børkje B, Skagen DW, Andersen KJ, Schrumpf E (1986)
Longitudinal distribution of mucosal enzymes in the human large bowel
Scand J Gastroenterol, 21 (8), 919-27
DOI 10.3109/00365528608996396, PubMed 3775257

FLATMARK A, BERGAN A, SODAL G, SCHRUMPF E, KVITTINGEN EA, JELLUM E, HALVORSEN S (1986)
DOES LIVER-TRANSPLANTATION CORRECT THE METABOLIC DEFECT IN HEREDITARY TYROSINEMIA
Transplant. Proc., 18 (1), 67-68

Kvittingen EA, Jellum E, Stokke O, Flatmark A, Bergan A, Sødal G, Halvorsen S, Schrumpf E, Gjone E (1986)
Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction
J Inherit Metab Dis, 9 (2), 216-24
DOI 10.1007/BF01799465, PubMed 3091928

Odegaard S, Børkje B, Skagen DW, Laerum OD, Schrumpf E (1986)
Enzyme activities in human gastric cancer and polyps
Scand J Gastroenterol, 21 (10), 1250-6
DOI 10.3109/00365528608996451, PubMed 3809999

Odegaard S, Børkje B, Skagen DW, Laerum OD, Schrumpf E (1986)
Enzyme activities in human gastric mucosa in gastritis and resected stomachs
Scand J Gastroenterol, 21 (10), 1257-64
DOI 10.3109/00365528608996452, PubMed 3810000

Odegaard S, Schrumpf E, Børkje B, Hamre E, Vetvik K, Laerum OD (1986)
[Ultrasonic diagnosis in parenchymal liver disease]
Tidsskr Nor Laegeforen, 106 (13), 1101-3
PubMed 3523825

Schrumpf E, Frøland S (1986)
[Viral hepatitis. New clinical aspects]
Tidsskr Nor Laegeforen, 106 (23), 1804-6
PubMed 3764854

Schrumpf E, Stray N, Flatmark A (1986)
Treatment of bleeding oesophageal varices
Scand J Gastroenterol, 21 (8), 897-9
DOI 10.3109/00365528608996392, PubMed 3535011

Publications 1985

Børkje B, Vetvik K, Odegaard S, Schrumpf E, Larssen TB, Kolmannskog F (1985)
Chronic pancreatitis in patients with sclerosing cholangitis and ulcerative colitis
Scand J Gastroenterol, 20 (4), 539-42
DOI 10.3109/00365528509089693, PubMed 3875140

Hauge ER, Schrumpf E (1985)
[Intrahepatic cholestasis. A review and a case report of benign recurrent intrahepatic cholestasis]
Tidsskr Nor Laegeforen, 105 (31), 2211-3
PubMed 4082133

Schrumpf E, Bergan A, Djøseland O, Fausa O, Flaten O, Skagen DW, Tronier B (1985)
The effect of gastric bypass operation on glucose tolerance in obesity
Scand J Gastroenterol Suppl, 107, 24-31
DOI 10.3109/00365528509099748, PubMed 3885381

Skrede S, Solberg HE, Ritland S, Blomhoff JP, Schrumpf E, Elgjo K (1985)
Follow-up and prospective studies of the classification of liver disease
Scand J Gastroenterol Suppl, 107, 40-51
DOI 10.3109/00365528509099751, PubMed 3856934

Vetvik K, Odegaard S, Schrumpf E, Arnesjö B (1985)
[Tumor of Vater's ampulla]
Tidsskr Nor Laegeforen, 105 (32), 2296-9
PubMed 4082141

Publications 1984

Børkje B, Odegaard S, Vetvik K, Schrumpf E (1984)
[Chronic pancreatitis associated with ulcerative colitis and sclerosing cholangitis. A case report]
Tidsskr Nor Laegeforen, 104 (8), 585-7
PubMed 6719423

Guldvog I, Linnestad P, Schrumpf E, Berstad A (1984)
Dopaminergic and adrenergic influence on gastric acid and pepsin secretion stimulated by food. The role of vagal innervation
Scand J Gastroenterol Suppl, 89, 113-6
PubMed 6429838

GULDVOG I, LINNESTAD P, SCHRUMPF E, BERSTAD A (1984)
DOPAMINERGIC AND ADRENERGIC INFLUENCE ON GASTRIC-ACID AND PEPSIN-SECRETION STIMULATED BY FOOD - THE ROLE OF VAGAL INNERVATION
Scand. J. Gastroenterol., 19 89, 113-116

Odegaard S, Vetvik K, Børkje B, Schrumpf E, Bakkevold K, Pedersen OM, Kråkenes J (1984)
[Ultrasonics and endoscopic retrograde cholangiopancreatography (ERCP). Value in suspected liver, biliary and pancreatic disease]
Tidsskr Nor Laegeforen, 104 (19-21), 1315-7
PubMed 6740630

Schrumpf E, Løtveit T (1984)
[Gallstone--surgical or drug therapy?]
Nord Med, 99 (6-7), 167-9
PubMed 6473086

Schrumpf E, Ritland S, Gjone E, Elgjo K, Smevik B (1984)
[Primary liver cancer. Diagnosis, therapy and prognosis]
Tidsskr Nor Laegeforen, 104 (3), 147-9
PubMed 6701849

Publications 1983

Guldvog I, Schrumpf E (1983)
[Acute upper gastrointestinal hemorrhage. New aspects in the prevention and treatment]
Tidsskr Nor Laegeforen, 103 (14), 1158-60
PubMed 6603678

Linnestad P, Erichsen A, Fausa O, Flaten O, Hanssen LE, Schrumpf E (1983)
The release of human pancreatic polypeptide, gastrin, gastric inhibitory polypeptide, and somatostatin in celiac disease related to the histological appearance of jejunal mucosa before and 1 year after gluten withdrawal
Scand J Gastroenterol, 18 (2), 169-75
DOI 10.3109/00365528309181579, PubMed 6143393

Linnestad P, Guldvog I, Schrumpf E (1983)
The effect of histamine, H1 and H2 agonists, and H1 and H2 antagonists on postprandial pancreatic polypeptide release in dogs
Scand J Gastroenterol, 18 (2), 165-8
DOI 10.3109/00365528309181578, PubMed 6143392

Linnestad P, Guldvog I, Schrumpf E (1983)
Effects of dopamine and dopamine antagonists on postprandial release of pancreatic polypeptide in dogs and in healthy volunteers
Scand J Gastroenterol, 18 (1), 81-5
DOI 10.3109/00365528309181563, PubMed 6144173

Linnestad P, Guldvog I, Schrumpf E (1983)
The effect of alpha- and beta-adrenergic agonists and blockers on postprandial pancreatic polypeptide release in dogs
Scand J Gastroenterol, 18 (1), 87-90
DOI 10.3109/00365528309181564, PubMed 6144174

Linnestad P, Schrumpf E (1983)
Pancreatic polypeptide release stimulated by food, secretin and cholecystokinin in chronic pancreatitis
Scand J Gastroenterol, 18 (3), 385-9
DOI 10.3109/00365528309181611, PubMed 6200922

Petrin P, Schrümpf E (1983)
[Initiation of a dental study as a pilot study in the framework of a military services study]
Osterr Z Stomatol, 80 (6), 233-6
PubMed 6583643

Talseth T, Schrumpf E, Ulrichsen H (1983)
Acute effects of intravenous cimetidine upon gastric secretion in patients with impaired renal function
Nephron, 33 (4), 244-7
DOI 10.1159/000182961, PubMed 6405296

Vatn MH, Schrumpf E, Talseth T (1983)
Effect of cimetidine on intrinsic factor secretion stimulated by different doses of pentagastrin in patients with impaired renal function
Scand J Gastroenterol, 18 (8), 1109-14
DOI 10.3109/00365528309181849, PubMed 6424229

Publications 1982

Brinch L, Teisberg P, Schrumpf E, Akesson I (1982)
The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis
Scand J Gastroenterol, 17 (4), 523-7
DOI 10.3109/00365528209182243, PubMed 7134879

Dolva LO, Hanssen KF, Flaten O, Skare S, Schrumpf E (1982)
Effect of thyrotropin-releasing hormone on gastric acid secretion in man
Scand J Gastroenterol, 17 (6), 775-80
DOI 10.3109/00365528209181092, PubMed 6818683

Kolmannskog F, Schrumpf E, Bergan A, Larsen S (1982)
Diagnostic value of computed tomography in pancreatic carcinoma: a comparison with other radiologic methods
Acta Radiol Diagn (Stockh), 23 (2), 131-41
DOI 10.1177/028418518202300209, PubMed 7090850

Kolmannskog F, Schrumpf E, Valnes K (1982)
Computed tomography and angiography in pancreatic apudomas and cystadenomas
Acta Radiol Diagn (Stockh), 23 (4), 365-72
DOI 10.1177/028418518202300404, PubMed 7158400

Linnestad P, Schrumpf E (1982)
Effect of cholinergic and adrenergic blockade on human pancreatic polypeptide secretion in healthy subjects
Scand J Gastroenterol, 17 (6), 801-9
DOI 10.3109/00365528209181097, PubMed 7156876

Schrumpf E, Fausa O, Førre O, Dobloug JH, Ritland S, Thorsby E (1982)
HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease
Scand J Gastroenterol, 17 (2), 187-91
DOI 10.3109/00365528209182038, PubMed 6982501

Schrumpf E, Fausa O, Kolmannskog F, Elgjo K, Ritland S, Gjone E (1982)
Sclerosing cholangitis in ulcerative colitis. A follow-up study
Scand J Gastroenterol, 17 (1), 33-9
DOI 10.3109/00365528209181041, PubMed 7134835

Schrumpf E, Gjone E (1982)
Hepatobiliary disease in ulcerative colitis
Scand J Gastroenterol, 17 (8), 961-4
PubMed 6762645

Schrumpf E, Gjone E (1982)
Physical activity and the gastrointestinal tract
Scand J Soc Med Suppl, 29, 69-70
PubMed 6958057

SCHRUMPF E, GJONE E (1982)
PHYSICAL-ACTIVITY AND THE GASTROINTESTINAL-TRACT
Scand. J. Soc. Med. (29), 69-70

Schrumpf E, Linnestad P (1982)
Effect of cholinergic, adrenergic, and dopaminergic blockade on gastrin secretion in healthy subjects
Scand J Gastroenterol, 17 (1), 29-31
DOI 10.3109/00365528209181040, PubMed 6127788

Skrede S, Solberg HE, Ritland S, Blomhoff JP, Schrumpf E, Elgjo K, Gjone E (1982)
Diagnostic and prognostic value of laboratory tests assessed in a follow-up study of 200 patients with liver disease
Clin Chem, 28 (5), 1177-81
PubMed 7074900

Publications 1981

Kolmannskog F, Schrumpf E, Bergan A, Larsen S (1981)
Diagnostic value of computer tomography in chronic pancreatitis: a comparison with current diagnostic tests
Acta Radiol Diagn (Stockh), 22 (6), 649-55
DOI 10.1177/028418518102200605, PubMed 7347115

Kolmannskog F, Aakhus T, Fausa O, Schrumpf E, Ritland S, Gjone E, Elgjo K (1981)
Cholangiographic findings in ulcerative colitis
Acta Radiol Diagn (Stockh), 22 (2), 151-7
DOI 10.1177/028418518102200208, PubMed 6269359

Schrumpf E, Bergan A, Blomhoff JP, Hoel PS, Kolmannskog F (1981)
Partial hepatectomy in Caroli's disease
Scand J Gastroenterol, 16 (5), 581-5
DOI 10.3109/00365528109182015, PubMed 7323694

SCHRUMPF E, BERGAN A, BLOMHOFF JP, HOEL PS, KOLMANNSKOG F (1981)
PARTIAL-HEPATECTOMY IN CAROLIS-DISEASE
Scand. J. Gastroenterol., 16 (5), 580-585

Schrumpf E, Giercksky KE, Nygaard K, Fausa O (1981)
Gastrin secretion before and after gastric bypass surgery for morbid obesity
Scand J Gastroenterol, 16 (6), 721-5
DOI 10.3109/00365528109180995, PubMed 7034160

Schrumpf E, Linnestad P, Nygaard K, Giercksky KE, Fausa O (1981)
Pancreatic polypeptide secretion before and after gastric bypass surgery for morbid obesity
Scand J Gastroenterol, 16 (8), 1009-14
DOI 10.3109/00365528109181020, PubMed 7038840

Stokkeland M, Schrumpf E, Hanssen AS, Myren J, Osnes M, Stadaas J (1981)
Incidence of malignancies of the Billroth II operated stomach. A prospective follow-up
Scand J Gastroenterol Suppl, 67, 169-71
PubMed 6941399

STOKKELAND M, SCHRUMPF E, HANSSEN AS, MYREN J, OSNES M, STADAAS J (1981)
INCIDENCE OF MALIGNANCIES OF THE BILLROTH-II OPERATED STOMACH - A PROSPECTIVE FOLLOW-UP
Scand. J. Gastroenterol., 16 67, 169-171

Publications 1980

Bohman T, Myren J, Flaten O, Schrumpf E (1980)
The effect of trimipramine, cimetidine and atropine on gastric secretion
Scand J Gastroenterol Suppl, 58, 53-6
PubMed 6929093

Bohman T, Myren J, Flaten O, Schrumpf E (1980)
The effect of trimipramine, cimetidine, and atropine on gastric secretion
Scand J Gastroenterol, 15 (2), 177-82
DOI 10.3109/00365528009181451, PubMed 7384741

BOHMAN T, MYREN J, FLATEN O, SCHRUMPF E (1980)
THE EFFECT OF TRIMIPRAMINE, CIMETIDINE AND ATROPINE ON GASTRIC-SECRETION
Scand. J. Gastroenterol., 15 58, 53-56

MYREN J, PETERSEN H, BERSTAD A, SCHRUMPF E (1980)
PAPERS PRESENTED AT THE SYMPOSIUM ON PATHO-PHYSIOLOGY AND DRUG-THERAPY OF PEPTIC-ULCER - OSLO, 15-17 MARCH 1979 .1. - INTRODUCTION
Scand. J. Gastroenterol., 15 58, 5

Schrumpf E (1980)
The effect of antacids on gastrin release
Scand J Gastroenterol Suppl, 58, 25-8
PubMed 6988939

SCHRUMPF E (1980)
THE EFFECT OF ANTACIDS ON GASTRIN-RELEASE
Scand. J. Gastroenterol., 15 58, 25-28

Schrumpf E, Elgjo K, Fausa O, Gjone E, Kolmannskog F, Ritland S (1980)
Sclerosing cholangitis in ulcerative colitis
Scand J Gastroenterol, 15 (6), 689-97
DOI 10.3109/00365528009181516, PubMed 7209379

Schrumpf E, Gjone E (1980)
[Physical activity and the gastrointestinal tract]
Tidsskr Nor Laegeforen, 100 (12B), 763-4
PubMed 7404515

Symposium on Pathophysiology and Drug Therapy of Peptic Ulcer, Myren J, Schrumpf E, Bergan T (1980)
Symposium on Pathophysiology and Drug Therapy of Peptic Ulcer
In Scandinavian journal of gastroenterology, Supplement, Taylor & Francis, Basingstoke, 58, 118 s.
BIBSYS 021231567

Vatn MH, Schrumpf E, Hanssen KF, Myren J (1980)
A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man
J Endocrinol Invest, 3 (3), 279-82
DOI 10.1007/BF03348276, PubMed 6159391

Publications 1979

Myren J, Schrumpf E, Bohman T, Skaug OE, Larsen S (1979)
Serum concentration of trimipramine (Surmontil) and gastric secretion of acid and pepsin following peroral administration of the drug in healthy humans
Scand J Gastroenterol, 14 (2), 237-40
DOI 10.3109/00365527909179876, PubMed 373073

Osnes M, Serck-Hanssen A, Myren J, Quigstad T, Schrumpf E, Dybdahl J, Melsom M (1979)
Malignancy in colonoscopically removed polyps
Front Gastrointest Res, 4, 198-201
DOI 10.1159/000402302, PubMed 428893

Schrumpf E, Gjone E (1979)
[Peptide-producing neoplasms in the gastrointestinal tract]
Tidsskr Nor Laegeforen, 99 (9-10), 465-6
PubMed 220750

Publications 1978

Bohman T, Schrumpf E, Myren J, Foss OP (1978)
The effect of TRIMIPRAMINE (Surmontil) on the stimulated gastric secretion and serum gastrin concentration in healthy students
Scand J Gastroenterol Suppl, 48, 7-49
PubMed 27861

BOHMAN T, SCHRUMPF E, MYREN J, FOSS OP (1978)
EFFECT OF TRIMIPRAMINE (SURMONTIL) ON STIMULATED GASTRIC-SECRETION AND SERUM GASTRIN CONCENTRATION IN HEALTHY STUDENTS
Scand. J. Gastroenterol., 13 48, 7-49

Osnes M, Petersen H, Schrumpf E (1978)
Comparison of juice obtained during duodenal aspiration and cannulation of the main pancreatic duct after stimulation with exogenous secretin in man
Scand J Gastroenterol, 13 (4), 453-8
DOI 10.3109/00365527809181921, PubMed 675156

Schrumpf E (1978)
The inhibitory action of somatostatin on the stomach
Adv Exp Med Biol, 106, 235-40
DOI 10.1007/978-1-4684-7248-6_31, PubMed 717165

Schrumpf E, Vatn MH, Hanssen KF, Myren J (1978)
A small dose of somatostatin inhibits the pentagastrin stimulated gastric secretion of acid, pepsin and intrinsic factor in man
Clin Endocrinol (Oxf), 8 (5), 391-5
DOI 10.1111/j.1365-2265.1978.tb02173.x, PubMed 348347

Stadaas JO, Schrumpf E, Hanssen KF (1978)
Somatostatin inhibits gastric motility in response to distention
Scand J Gastroenterol, 13 (2), 145-8
DOI 10.3109/00365527809181740, PubMed 635455

Publications 1977

Bohmann T, Schrumpf E, Myren J (1977)
The effect of trimipramine (Surmontil) on gastric secretion and the serum gastrin release in healthy young students
Scand J Gastroenterol Suppl, 43, 7-17
PubMed 323962

BOHMANN T, SCHRUMPF E, MYREN J (1977)
EFFECT OF TRIMIPRAMINE (SURMONTIL) ON GASTRIC-SECRETION AND SERUM GASTRIN RELEASE IN HEALTHY YOUNG STUDENTS
Scand. J. Gastroenterol., 12 43, 7-17

Grabner P, Semb LS, Schrumpf E, Myren J (1977)
Plasma gastrin and gastric secretory response to duodenal perfusion with liver extract in healthy human subjects
Scand J Gastroenterol, 12 (7), 865-8
DOI 10.3109/00365527709181731, PubMed 339324

Normann T, Normann E, Schrumpf E, Gautvik KM (1977)
Secretion of calcitonin and gastrin in rats with transplanted medullary thyroid carcinoma
Acta Pathol Microbiol Scand A, 85A (1), 63-72
DOI 10.1111/j.1699-0463.1977.tb03869.x, PubMed 835355

Osnes M, Lotveit T, Nakken KF, Nordshus T, Schrumpf E, Skjennald A (1977)
[Current diagnostic possibilities in pancreatic diseases]
Tidsskr Nor Laegeforen, 97 (6), 297-300
PubMed 847676

Schrumpf E, Myren J, Semb LS, Vatn MH (1977)
The effect of atropine on insulin stimulated gastric secretion and gastrin release
Mater Med Pol, 9 (2), 101-3
PubMed 895183

Schrumpf E, Serck-Hanssen A, Stadaas J, Aune S, Myren J, Osnes M (1977)
Mucosal changes in the gastric stump 20-25 years after partial gastrectomy
Lancet, 2 (8036), 467-9
DOI 10.1016/s0140-6736(77)91599-9, PubMed 70685

Vatn MH, Schrumpf E, Hanssen KF, Myren J (1977)
The effect of somatostatin on pentagastrin-stimulated gastric secretion and on plasma gastrin in man
Scand J Gastroenterol, 12 (7), 833-9
DOI 10.3109/00365527709181727, PubMed 339322

Publications 1976

Grabner P, Semb LS, Schrumpf E, Myren J (1976)
The intestinal phase of gastric secretion. Response to liver extract infusion into the proximal jejunum of healthy human subjects
Scand J Gastroenterol, 11 (4), 415-9
PubMed 935804

GRABNER P, SEMB LS, SCHRUMPF E, MYREN J (1976)
INTESTINAL PHASE OF GASTRIC-SECRETION - RESPONSE TO LIVER EXTRACT INFUSION INTO PROXIMAL JEJUNUM OF HEALTHY HUMAN SUBJECTS
Scand. J. Gastroenterol., 11 (4), 415-419

Schrumpf E, Vatn MH, Hanssen KF, Semb LS, Myren J (1976)
The effect of somatostatin on gastrin release and gastric secretion
Scand J Gastroenterol Suppl, 42, 41-2
PubMed 1070794

SCHRUMPF E, VATN MH, HANSSEN KF, SEMB LS, MYREN J (1976)
EFFECT OF SOMATOSTATIN ON GASTRIN RELEASE AND GASTRIC-SECRETION
Scand. J. Gastroenterol., 11 42, 41-42

Schrumpf E, Vatn MH, Hanssen KF, Semb S, Myren J (1976)
Somatostatin inhibits insulin-stimulated gastrin release and gastric secretion of acid, pepsin, and intrinsic factor (IF) in duodenal ulcer patients
Scand J Gastroenterol, 11 (5), 517-20
PubMed 785589

Solhaug JH, Schrumpf E (1976)
Effect of small bowel bypass on serum gastrin levels and gastric acid secretion in man
Scand J Gastroenterol, 11 (3), 329-32
PubMed 1273508

Publications 1975

Petersen H, Schrumpf E, Myren J (1975)
Fasting serum gastrin and basal gastric acid secretion
Scand J Gastroenterol, 10 (7), 721-4
PubMed 1188305

Vatn MH, Schrumpf E, Myren J (1975)
The effect of carbachol and pentagastrin on the gastric secretion of acid pepsin, and intrinsic factor (IF) in man
Scand J Gastroenterol, 10 (1), 55-8
PubMed 235784

VATN MH, SCHRUMPF E, MYREN J (1975)
EFFECT OF CARBACHOL AND PENTAGASTRIN ON GASTRIC-SECRETION OF ACID, PEPSIN, AND INTRINSIC FACTOR(IF) IN MAN
Scand. J. Gastroenterol., 10 (1), 55-58

Vatn MH, Semb LS, Schrumpf E (1975)
The effect of atropine and vagotomy on the secretion of gastric intrinsic factor (IF) in man
Scand J Gastroenterol, 10 (1), 59-64
PubMed 235785

VATN MH, SEMB LS, SCHRUMPF E (1975)
EFFECT OF ATROPINE AND VAGOTOMY ON SECRETION OF GASTRIC INTRINSIC FACTOR(IF) IN MAN
Scand. J. Gastroenterol., 10 (1), 59-64

Publications 1974

Schrumpf E (1974)
Studies on the regulation of the plasma gastrin concentration
Forfatteren, Oslo, 1b.(fl.pag.)
BIBSYS 010725377

Schrumpf E, Myren J (1974)
Effect of atropine on plasma concentration of gastrin in fasting subjects
Scand J Gastroenterol, 9 (2), 123-5
PubMed 4818390

Schrumpf E, Roland M, Liavåg I (1974)
Serum gastrin and gastric acid secretion before and after proximal gastric vagotomy
Scand J Gastroenterol, 9 (2), 115-8
PubMed 4818388

Schrumpf E, Stadaas J (1974)
Effect of gastric distention on motility and plasma gastrin concentration before and after secretin administration
Scand J Gastroenterol, 9 (2), 119-22
PubMed 4818389

Schrumpf E, Vatn MH, Semb LS (1974)
Effect of atropine on insulin-stimulated gastrin release and gastric secretion of acid, pepsin, and intrinsic factor (IF)
Scand J Gastroenterol, 9 (7), 665-9
PubMed 4610710

Stadaas J, Schrumpf E (1974)
Intragastric pressure-volume relationship and gastrin release after distention of separate parts of the stomach
Scand J Gastroenterol, 9 (8), 781-5
PubMed 4432051

Stadaas J, Schrumpf E, Haffner JF (1974)
The effect of gastric distention on gastric motility and serum gastrin in acutely vagotomized pigs
Scand J Gastroenterol, 9 (2), 127-31
PubMed 4818391

STADAAS J, SCHRUMPF E, HAFFNER JFW (1974)
EFFECT OF GASTRIC DISTENTION ON GASTRIC MOTILITY AND SERUM GASTRIN IN ACUTELY VAGOTOMIZED PIGS
Scand. J. Gastroenterol., 9 (2), 127-131

Vatn MH, Berstad A, Schrumpf E (1974)
The effect of calcium and pentagastrin on the gastric secretion of acid, pepsin, and intrinsic factor (IF) in man
Scand J Gastroenterol, 9 (7), 697-701
PubMed 4610713

VATN MH, BERSTAD A, SCHRUMPF E (1974)
EFFECT OF CALCIUM AND PENTAGASTRIN ON GASTRIC-SECRETION OF ACID, PEPSIN, AND INTRINSIC-FACTOR (IF) IN MAN
Scand. J. Gastroenterol., 9 (7), 697-701

Publications 1973

Schrumpf E, Myren J (1973)
The effect of secretin on plasma concentration of gastrin in fasting patients with carcinoma of the stomach
Scand J Gastroenterol, 8 (6), 479-82
PubMed 4772201

SCHRUMPF E, MYREN J (1973)
EFFECT OF SECRETIN ON PLASMA CONCENTRATION OF GASTRIN IN FASTING PATIENTS WITH CARCINOMA OF STOMACH
Scand. J. Gastroenterol., 8 (6), 479-482

Schrumpf E, Petersen H, Berstad A, Myren J, Rosenlund B (1973)
The effect of secretin on plasma gastrin in the Zollinger-Ellison syndrome
Scand J Gastroenterol, 8 (2), 145-50
PubMed 4697075

SCHRUMPF E, PETERSEN H, BERSTAD A, MYREN J, ROSENLUND B (1973)
EFFECT OF SECRETIN ON PLASMA GASTRIN IN ZOLLINGER-ELLISON SYNDROME
Scand. J. Gastroenterol., 8 (2), 145-150

Schrumpf E, Semb LS (1973)
The metabolic clearance rate and half-life of synthetic human gastrin in dogs
Scand J Gastroenterol, 8 (3), 203-7
PubMed 4724919

SCHRUMPF E, SEMB LS (1973)
METABOLIC CLEARANCE RATE AND HALF-LIFE OF SYNTHETIC HUMAN GASTRIN IN DOGS
Scand. J. Gastroenterol., 8 (3), 203-207

Schrumpf E, Semb LS, Vold H (1973)
Metabolic clearance and disappearance rates of synthetic human gastrin in man
Scand J Gastroenterol, 8 (8), 731-4
PubMed 4771113

Publications 1972

Schrumpf E, Sand T (1972)
Radioimmunoassay of gastrin with activated charcoal
Scand J Gastroenterol, 7 (8), 683-7
DOI 10.3109/00365527209180977, PubMed 4640642

Publications 1971

Schrümpf E (1971)
[Treatment of the microbial lower-leg eczema with special reference to diabetes mellitus]
Z Haut Geschlechtskr, 46 (19), 637-9
PubMed 5137246

Publications 1970

Schrumpf E, Bjelke E (1970)
Vitamin B 12 in the serum and the cerebrospinal fluid
Acta Neurol Scand, 46 (2), 243-8
DOI 10.1111/j.1600-0404.1970.tb05620.x, PubMed 5431458

Publications 1969

Schrümpf E (1969)
[Supplemental effect of beta-aescin by vasodilator agents]
Wien Med Wochenschr, 119 (42), 721-2
PubMed 4391303

Schrümpf E (1969)
[Significance of local antibiotic therapy in the treatment of indolent ulcer. (Clinical results)]
Z Haut Geschlechtskr, 44 (18), 775-6
PubMed 5382946

Publications 1968

Schrümpf E (1968)
[Dermatologic experiences with a new ointment foundation with the saturated fatty acid glyceride base]
Wien Med Wochenschr, 118 (3), 47-52
PubMed 4233268

Publications 1966

Schrümpf E (1966)
[Therapeutic results with a new ointment foundation on basis of synthetic glycerides of saturated fatty acids]
Dermatol Wochenschr, 152 (26), 660-71
PubMed 5963477